KPJ Healthcare Berhad, an investment holding company, (5878) Fair Value & Analysis
Healthcare · MY · Market cap 14.0B MYR
Fair value as of: Jun 24, 2026
From 26 valuation models · updated 5 days ago
Share price +1.2% over the past month.
Price vs Fair Value (12 months)
12‑month range 2.30 MYR – 3.47 MYR · fair‑value band 1.36 MYR – 2.27 MYR · the 3.20 MYR price screens above the 1.82 MYR fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
KPJ Healthcare Berhad, an investment holding company, (5878) currently trades at 3.20 MYR, while our model-based Fair Value estimate is 1.82 MYR — implying the stock looks roughly 43.1% overvalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, KPJ Healthcare Berhad, an investment holding company, generated revenue of 4.3B MYR at a net margin of 8.7%. Revenue grew 8.6% year over year. It earns a return on equity of 14.0%. Net debt stands at 3.0B MYR. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
KPJ Healthcare Berhad, an investment holding company, engages in the operation of specialist hospitals in Malaysia, Thailand, and Australia. It provides pathology and laboratory services; management and engineering maintenance services for specialist hospitals; and medical and consultancy services for eye care, as well as maintenance services for medical equipment. The company also operates a private university college of nursing and allied health; a pharmacy retail outlet; medical service provider; polyclinic; assisted living care, after birth care, and rehabilitation centers; retirement village facilities; pharmacy retail outlet; and a training center, as well as operates and manages an ambulatory care center. In addition, it engages in marketing and distributing medical, pharmaceutical, and consumer healthcare products; provision of healthcare information system and information technology related services; and rental of software and human resource information system; and property…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
KPJ Healthcare Berhad, an investment holding company, reported revenue of 4.3B MYR in FY2025 versus 2.6B MYR in FY2021, a compound +12.8%/yr. Reported net income was 366M MYR in FY2025, compounding +63.6%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.67 MYR | 3.08 MYR | -64% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $164.77 | $280.85 | +70% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is KPJ Healthcare Berhad, an investment holding company, (5878) undervalued?
What is the fair value of 5878?
What is the quality score of 5878?
What is the revenue of KPJ Healthcare Berhad, an investment holding company, (5878)?
What is the net profit margin of 5878?
Does KPJ Healthcare Berhad, an investment holding company, pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.